Note: Ingredients listed on restricted chemical lists
EC/CAS
231-673-0/7681-57-4
Name of the chemical
Sodium metabisulfite
Concentration
>=3-<10
EC/CAS
215-125-8/1303-86-2
Name of the chemical
Dibortrioxid (790/2009)
Concentration
>=0,3-<1
General Information
Version
7.2
Revision date
2023-03-08
Product name
Carestream Kodak Processing chemicals
REACH No
This
Emergency telephone
800-424-9300 CHEMTREC (USA) +1-703- 527-3887 CHEMTREC (International) 24
Icons in SDS
Company Information
company name
Sigma-Aldrich Inc
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H318, H360FD
Hazard statements
Code
Statements
H318
Causes serious eye damage
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Classification
2.2 Label elements
Labelling
Signal word
Danger
Hazard statements
H318 Causes serious eye damage. H360FD May damage fertility. May damage the unborn child. Restricted to professional users.
Precautionary statements
P202 Do not handle until all safety precautions have been read and understood. P280 Wear protective gloves/ protective clothing/ eye protection/ face protection. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P405 Store locked up. P501 Dispose of contents/ container to an approved waste disposal plant.
Supplemental label elements
none
2.3 Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher.
ECOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
TOXICOLOGICAL INFORMATION
The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Commission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
